Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Psilocybin Brain Stimulation and Imaging Pilot Study

NCT: NCT06835699 · ACTIVE_NOT_RECRUITING

NCT IDNCT06835699
StatusACTIVE_NOT_RECRUITING
Start Date2025-04-18
Completion2026-08

Brief Summary

This open-label pilot psilocybin administration study investigates the influence of psilocybin on brain function and cognitive control functions in clinically and psychiatrically healthy volunteers. Participants will undergo experimental drug administration sessions after careful screening and preparation. Participants will also have brain activity measured using electroencephalogram (EEG) also during non-invasive brain stimulation using Transcranial Magnetic Stimulation (TMS).

Frequently Asked Questions

What is Psilocybin Brain Stimulation and Imaging Pilot Study?

Psilocybin Brain Stimulation and Imaging Pilot Study is a clinical trial registered under NCT06835699. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06835699?

The current status of NCT06835699 (Psilocybin Brain Stimulation and Imaging Pilot Study) is: ACTIVE_NOT_RECRUITING.

When did Psilocybin Brain Stimulation and Imaging Pilot Study start?

Psilocybin Brain Stimulation and Imaging Pilot Study started on 2025-04-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.